InvestorsHub Logo
Followers 65
Posts 23986
Boards Moderated 0
Alias Born 11/23/2016

Re: None

Monday, 12/12/2016 6:03:44 PM

Monday, December 12, 2016 6:03:44 PM

Post# of 464035
MacFarlane and Cauldfield seem very sure to run the P2/3 Alzheimer trial. I can only think that Australia is funding the trial and that this is the partnership for Alzheimer's that Missling has been referring to all along.

Rett's and PD can be managed and funded by Anavex probably with some grants. Guessing the magic $8M is from as yet unannounced grants. With A2-73 hitting the market via Rett's in 2017/18, all this if true could mean no dilution - ever!

Or am I miss interpreting?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News